ArticleOncogene2023

AXL activates YAP through the EGFR-LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma.

Kento Okamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.